👉 Read below about the experience of Hadyn Duncan, Cell Line Manager and Senior R&D Scientist at Rekom Biotech
@medinadiscovery.bsky.social #SuccessStory #HTS #AnalyticalBiochemistry #ELISA #DrugDiscovery #FundacionMEDINA
In collaboration with Rekom Biotech, we aimed at overcoming these limitations and developed a quick, cost-effective, and miniaturized method that surpasses traditional ELISA performance.
Validating antigen-antibody interactions is a cornerstone of R&D, yet traditional methods like ELISA can often become bottlenecks due to their cost, time requirements, and lack of scalability.
@medinadiscovery.bsky.social is part of the #NOVA-VRE project, aimed at developing new therapies against infections caused by vancomycin-resistant Enterococcus faecium.
Read the full piece here:
www.medinadiscovery.com/medina-parti...
Stay tuned for updates! 🔬
👉 Read below about the experience of Mamatha B Nijaguna, Principal Investigator at Institute for Bioengineering of Catalonia (IBEC)
#SuccessStory #HTS #DrugDiscovery #Biotech #ResearchCollaboration Universidad de Granada Junta de Andalucía MSD España #FundacionMEDINA
At @medinadiscovery.bsky.social, we integrate our expertise in Thermal Shift Assays and orthogonal binding assays to transform a discovery phase into a robust and reliable prioritization strategy.
Hit prioritization through orthogonal binding assays.
In drug discovery, identifying hits is only the beginning; the real challenge lies in prioritizing them correctly to eliminate false positives and ensure only the most promising candidates move forward.
👉 Read below about the experience of Prof. Ruben Martinez-Buey at the University of Salamanca.
#SuccessStory #HTS #DrugDiscovery #Biotech #ResearchCollaboration #FundacionMEDINA Universidad de Salamanca Universidad de Granada Junta de Andalucía MSD España #FundacionMEDINA
At @medinadiscovery.bsky.social we are experts in developing automated and miniaturized assays starting from your proof-of-concept. We transform your experimental assay into a fully operational, high-throughput platform
From a conventional enzymatic assay to a high-throughput screening platform in weeks.
Transitioning an optimized in vitro assay from an academic setting to high-throughput screening requires more than just automation; it demands a fundamental redesign of the assay’s robustness.
👉For detailed specifications on our LC-MS solutions or to discuss a custom ADME-Tox protocol, please contact our scientific team.
#DrugDiscovery #Preclinical #ADMETox #MetaboliteIdentification
Universidad de Granada Junta de Andalucía MSD España #FundacionMEDINA
At @medinadiscovery.bsky.social , we offer a comprehensive approach to Metabolite Profiling. Our objective is to provide the chemical evidence necessary to rule out safety risks before moving to regulatory phases.
The evaluation of metabolic stability is a standard procedure in early drug discovery. However, relying solely on disappearance rates often overlooks the formation of active or reactive metabolites. These unidentified species can cause toxicity, leading to late-stage dropout.
We offer the infrastructure of a large center with the accessibility of a dedicated service provider
Ready to de-risk your candidate?
www.medinadiscovery.com
#Preclinical #ADMETox #DrugDiscovery #Pharma #Biotech Universidad de Granada Junta de Andalucía MSD España
Our goal isn't just to generate data, but to generate exploratory knowledge that allows you to refine hypotheses and select the best drug candidate for optimization.
Entering regulatory phases with the wrong candidate is a costly mistake. The key to efficiency in Drug Discovery lies in the preliminary phase: Non-GLP Preclinical Research.
At @medinadiscovery.bsky.social , we offer a flexible and cost-effective approach to Non-GLP Preclinical Studies.
Universidad de Granada MSD España Junta de Andalucía #CSIC #EstacionExperimentaldelZaidin #ZaidinCSIC #Biotecnologia #BiotecnologiaMicrobiana #Microbiologia #Innovacion #Investigacion #TransferenciaDeConocimiento #FundacionMEDINA
Ayer en @medinadiscovery.bsky.social recibimos la visita de los alumnos del Máster en Biología Agraria y Acuicultura de la Universidad de Granada, acompañados por el profesor Alberto Bago, Estación Experimental del Zaidín-CSIC.
At @medinadiscovery.bsky.social , we use iPSC-based gene modeling to seek therapeutic options for rare diseases.
Research into rare diseases is not just about the few; it is also about advancing our fundamental understanding of human biology through cutting-edge science.
When each individual disease might only have a few cases around the world, tools like iPSC technology and gene editing become fundamental to generate cell-based models that help understanding the mechanisms underlying rare diseases.
Tomorrow is Rare Disease Day
While individual rare diseases affect a small number of people, their collective impact is a global health challenge.
#RareDiseaseDay #GeneEditing #iPSC #Biotech
🚀 New Article Published! Unlocking the Power of Non GLP Preclinical Studies in Drug Discovery!
www.medinadiscovery.com/wp-content/u...
👉 Elevate your pipeline. Reduce risk. Accelerate innovation
#ADME-tox #DrugDevelopment #BienestarAnimal #SECAL #COSCE #FundacionMEDINA #AnimalResearch
#NPC21 #metabolomics #naturalproducts #discovery DTU - Technical University of Denmark DTU Biosustain Fundacion MEDINA Eberhard Karls Universität Tübingen European Union NaiconsNewcastle University Wageningen University & Research c-LEcta GmbH
Last week, our doctoral student Gioele Pecin presented a poster at the Natural Products in the 21st Century conference in #Leuven. He explained how he managed to heterologously express the main genes of the biosynthetic cluster of a new fungal natural product in a black yeast host.
#FundaciónMEDINA NanoTemper Technologies Instituto de Química Física "Blas Cabrera" (IQF-CSIC) Universidad de Granada MSD España Junta de Andalucía #HighThroughputScreening #DrugDiscovery #MolecularInteractions #Biophysics #IQFSymposium
Excited to participate in the IQF Technical-Scientific Symposium in Madrid, March 10th.
Join us to explore new trends in molecular interactions.
Full agenda and registration: nanotempertech.com/events/works...
The initiative, led by the Confederación de Sociedades Científicas de España (COSCE) together with the European Animal Research Association (EARA), continues to grow and is now a recognized reference across Europe for its impact and commitment to openness.
At @medinadiscovery.bsky.social , as a committed member of the COSCE Agreement for #Transparency in animal research, we are pleased to share the VIII Annual Transparency Report.
🔍 Learn more and access the full report below 👇
cosce.org/presentacion...
📍 See you on June 10–11 in #Amsterdam, The #Netherlands.
#ACIBiopesticidesEurope #Biopesticides #Microbiology #FungalBiodiversity #Biocontrol #SustainableAgriculture @universidadgranada.bsky.social Junta de Andalucía MSD España #FundaciónMEDINA #Biodiversity #Naturalfumigants
@medinadiscovery.bsky.social at the ACI Biopesticides Europe 2026! 🚀
Don’t miss the conference "Harnessing the Potential of Natural Products for the discovery of new biopesticides " by Victor González Menéndez, Principal Scientist in Microbiology and Fungal Collection Manager at MEDINA